Mike Laptev / Shutterstock.com
15 August 2014Americas
PhRMA reacts to FDA’s biosimilars guidance
The Pharmaceutical Research and Manufacturers of America (PhRMA) has voiced concerns about the US Food and Drug Administration’s (FDA’s) draft guidance on biosimilars, which it suggests if enacted, could have an impact on the safety of biosimilar products.
